3.2 Closed System Transfer Devices (CSTDs)

Why CSTDs Are Tested as a Distinct Topic

A Closed System Transfer Device (CSTD) is not a room or a cabinet — it's a set of connector components (vial adapters, syringe adapters, IV tubing connectors) that mechanically prevent two things at once: environmental contaminants from entering the drug pathway, and hazardous drug (HD) or HD vapor from escaping into the environment. Because a CSTD travels with the drug from the C-PEC all the way to the patient's bedside, it is tested as its own topic distinct from C-PECs, C-SECs, or PPE — and the exam repeatedly probes exactly where USP <800> makes CSTDs mandatory versus merely advisable.

Required vs. Recommended: The Line the Exam Tests

This distinction is one of the most commonly missed points in the Engineering Controls domain:

Memorize the asymmetry: the bedside/administration step carries the hard requirement, while the compounding step carries a strong best-practice recommendation. A pharmacy that compounds an IV antineoplastic drug (using CSTD-compatible vials) without attaching a CSTD is not technically in violation of the requirement — but a nurse who administers that same drug without a CSTD, when a compatible product and dosage form exist, is.

Memory Tip: "Administration = Absolute requirement." Compounding only gets a recommendation.

How CSTDs Work

Commercially available CSTD systems generally use one of two mechanisms:

• Membrane-to-membrane (dry connection) systems — two membranes press together and open only at the point of connection, so the fluid pathway is never exposed to open air. PhaSeal and Equashield are widely cited examples.
• Air-cleaning / filter-based systems — contaminated air displaced during transfer is drawn through a 0.2-micron hydrophobic filter before being vented, rather than escaping directly. ChemoClave, Tevadaptor, and OnGuard are examples used in practice.

The exam does not require memorizing engineering diagrams of each product, but it does expect you to recognize brand names (PhaSeal, Equashield, ChemoClave, Tevadaptor, OnGuard) as CSTDs rather than as C-PECs, PPE, or spill-kit components — a common distractor pattern.

CSTDs exist as a category because engineering controls like a BSC or CACI, while highly effective, do not eliminate every route of exposure by themselves. Documented surface-contamination studies at pharmacies that already used properly certified C-PECs showed measurable residue on gloves, counters, and IV bags — evidence that open-air connections during spiking, priming, and vial access were still letting drug escape the system even inside a well-run C-PEC. That evidence is the practical reason NIOSH began recommending CSTDs as a supplemental layer of protection on top of, not instead of, a compliant C-PEC.

Limitations: Not Every Drug or Dosage Form Is CSTD-Compatible

CSTDs cannot be assumed to work universally:

• Chemical incompatibility — some HDs react with CSTD component materials. Bendamustine, for example, is documented as incompatible with certain CSTD components, so a drug/CSTD combination known to be chemically or physically incompatible must never be used together; check the manufacturer's compatibility documentation, not just the NIOSH hazard list.
• Dosage-form incompatibility — CSTDs are not usable for intrathecal preparations, irrigations, ophthalmic products, or topical creams/ointments/gels. These dosage forms have no CSTD-compatible administration pathway, which is exactly why the USP <800> administration requirement is conditioned on "when a therapeutically appropriate dosage form is available."

Where CSTD Components Attach

A single CSTD "system" is really a family of matched components used at different points in the drug's path, and the exam may describe one piece without naming the whole system:

• Vial adapter — attaches to the drug vial during reconstitution/withdrawal in the C-PEC (compounding step)
• Syringe adapter — attaches to the syringe used to draw up or transfer the dose
• IV bag/tubing connector (bag spike or in-line adaptor) — attaches at the bedside when the dose is connected to the patient's IV line (administration step)

All three components must come from a mutually compatible CSTD product line — mixing a vial adapter from one manufacturer with a bag connector from another can break the closed-system seal even if each piece is individually a legitimate CSTD component.

Exam Scenario

An oncology nurse is preparing to administer an IV antineoplastic HD for which a CSTD-compatible vial and tubing set are stocked on the unit — but the nurse instead spikes the bag using standard non-CSTD tubing to save time. This is a USP <800> violation because CSTD use during administration of antineoplastic HDs is required whenever a compatible dosage form is available, not merely recommended. Compare that to a compounding pharmacist preparing the same drug in the C-PEC without a CSTD attachment: while strongly discouraged and against best practice, the compounding step alone is governed by a recommendation, not an absolute requirement.

Common Trap

Questions sometimes describe a compounding scenario and ask whether skipping a CSTD is "prohibited." Read carefully for whether the scenario is compounding (recommended) or administration (required) before choosing an answer — the correct choice often hinges entirely on that one word.